PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30623574-8	2019	AZD-9291 was more effective than Erlotinib in inhibiting phospho-EGFR, and downstream phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and phopho-signal transducer and activator of transcription 3 (p-STAT3) pathway signaling.	osimertinib	0-8	protein tyrosine kinase 2 beta	Homo sapiens	116-132	
30145802-4	2019	AZD9291 decreased the levels of phosphoinositide-3 kinase (PI3K), protein kinase B (Akt), and phosphorylated Akt.	osimertinib	0-7	protein tyrosine kinase 2 beta	Homo sapiens	66-82	
29332537-5	2018	In PC-9-IR cells, AZD9291 remarkably decreases phosphorylation levels of EGFR, extracellular regulated protein kinase (ERK), and protein kinase B (AKT).	osimertinib	18-25	protein tyrosine kinase 2 beta	Homo sapiens	129-145